Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$370K Sell
19,917
-31,658
-61% -$631K ﹤0.01% 1763
2026
Q1
$970K Buy
51,575
+36,096
+233% +$678K ﹤0.01% 1293
2025
Q4
$242K Buy
+15,479
New +$230K ﹤0.01% 1705
2025
Q3
Sell
-265,253
Closed -$3.5M 1652
2025
Q2
$3.5M Buy
265,253
+3,842
+1% +$48.4K ﹤0.01% 984
2025
Q1
$3.5M Sell
261,411
-49,660
-16% -$743K ﹤0.01% 1035
2024
Q4
$4.55M Buy
311,071
+235,771
+313% +$3.68M ﹤0.01% 1000
2024
Q3
$1.21M Buy
+75,300
New +$1.34M ﹤0.01% 1252
2023
Q4
Sell
-109,952
Closed -$2.25M 2053
2023
Q3
$2.25M Buy
+109,952
New +$2.19M ﹤0.01% 1149
2023
Q2
Sell
-202
Closed -$3.68K 2105
2023
Q1
$3.68K Hold
202
﹤0.01% 2026
2022
Q4
$4.59K Buy
+202
New +$4.24K ﹤0.01% 1854
2021
Q3
Sell
-8,338
Closed -$128K 1608
2021
Q2
$128K Buy
+8,338
New +$130K ﹤0.01% 1447

Other funds holding NOV

Amundi's NOV Position: Q2 2026 in Review

Amundi reduced its NOV (NOV) stake by 61% in Q2 2026, selling an estimated $631K and leaving 19,917 shares worth $370K. The position accounts for ﹤0.01% of the portfolio, ranked #1763.

Amundi first reported a position in NOV in Q2 2021 and has held it in 11 quarters since. The position peaked at $4.55M in Q4 2024. 489 funds tracked by Wall St. Rank hold NOV as of Q2 2026.

  • Amundi held 19,917 shares of NOV worth $370K as of Q2 2026.
  • Amundi sold 31,658 NOV shares in Q2 2026, an estimated $631K.
  • NOV made up ﹤0.01% of Amundi's portfolio in Q2 2026, its #1763 holding.
  • Amundi first reported a position in NOV in Q2 2021 and has held it in 11 quarters since.
  • Amundi's NOV position peaked at $4.55M in Q4 2024.
  • 489 funds tracked by Wall St. Rank held NOV as of Q2 2026.

Based on Amundi's 13F filing for Q2 2026, filed 11 Aug 2026.